Real-World Outcomes of Iptacopan in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Bassanese G, Weingarten AM, Marasà M, Mancuso MC, Quintana Porras LF, Bagchi S, Alberici F, Boyer O, Cirillo L, Geßner M, Giannese D, Klaus G, Harambat J, Hidalgo RL, Hirt-Minkowski P, Huerta A, Jauhal A, Loos S, Lundberg S, Maritati F, Massart A, Servais A, Sinico RA, Schröder-Braunstein J, Vivarelli M, Schaefer F, CompCure Consortium27, CompCure Consortium.

Open source

DOI
10.1016/j.ekir.2026.107062
Published
2026-09-03
Container
Kidney Int Rep
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.107062,
  title = {Real-World Outcomes of Iptacopan in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.},
  author = {Bassanese G and  Weingarten AM and  Marasà M and  Mancuso MC and  Quintana Porras LF and  Bagchi S and  Alberici F and  Boyer O and  Cirillo L and  Geßner M and  Giannese D and  Klaus G and  Harambat J and  Hidalgo RL and  Hirt-Minkowski P and  Huerta A and  Jauhal A and  Loos S and  Lundberg S and  Maritati F and  Massart A and  Servais A and  Sinico RA and  Schröder-Braunstein J and  Vivarelli M and  Schaefer F and  CompCure Consortium27 and  CompCure Consortium.},
  year = {2026},
  journal = {Kidney Int Rep},
  doi = {10.1016/j.ekir.2026.107062},
  url = {https://doi.org/10.1016/j.ekir.2026.107062}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes of Iptacopan in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
AU  - Bassanese G
AU  -  Weingarten AM
AU  -  Marasà M
AU  -  Mancuso MC
AU  -  Quintana Porras LF
AU  -  Bagchi S
AU  -  Alberici F
AU  -  Boyer O
AU  -  Cirillo L
AU  -  Geßner M
AU  -  Giannese D
AU  -  Klaus G
AU  -  Harambat J
AU  -  Hidalgo RL
AU  -  Hirt-Minkowski P
AU  -  Huerta A
AU  -  Jauhal A
AU  -  Loos S
AU  -  Lundberg S
AU  -  Maritati F
AU  -  Massart A
AU  -  Servais A
AU  -  Sinico RA
AU  -  Schröder-Braunstein J
AU  -  Vivarelli M
AU  -  Schaefer F
AU  -  CompCure Consortium27
AU  -  CompCure Consortium.
PY  - 2026
JO  - Kidney Int Rep
DO  - 10.1016/j.ekir.2026.107062
UR  - https://doi.org/10.1016/j.ekir.2026.107062
ER  - 

APA

G, B., AM, W., M, M., MC, M., LF, Q. P., S, B., F, A., O, B., L, C., M, G., D, G., G, K., J, H., RL, H., P, H., A, H., A, J., S, L., S, L., F, M., A, M., A, S., RA, S., J, S., M, V., F, S., Consortium27, C., & Consortium., C. (2026). Real-World Outcomes of Iptacopan in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.. Kidney Int Rep. https://doi.org/10.1016/j.ekir.2026.107062

Source records